Sempervirens Venture Capital

SemperVirens focuses on early-stage investments in health tech, fintech, and workforce tech companies that are reshaping the relationship between employers and employees.

SemperVirens closed two funds totaling $177 million in March 2025:

• Core Fund III: Raised $141 million for early-stage investments in companies.
• Growth Opportunity Fund II: Raised $36 million to support growth-stage investments in top-performing companies from their portfolio.

Limited Partners (LPs) in these funds include Paychex, ADP Ventures, Healthworx, The Cigna Group Ventures, Guardian, MetLife, Unum, Strada Education Foundation, Impact Engine, and more.

Leadership

• Robby Peters: Co-founder and Managing Partner
• Allison Baum Gates: General Partner

‍

Investment Strategy

SemperVirens employs a three-pronged investment strategy:

• Access: Connecting entrepreneurs with key stakeholders, channel partners, and end-buyers within their extensive network to foster meaningful relationships and create value.
• Analyze: Utilizing real-time market insights from advisors, investors, and partners to identify opportunities for product transformation and achieving product-market fit before making investments.
• Amplify: Accelerating portfolio growth by leveraging access to buyers across various company sizes, from SMBs to Fortune 500, and reaching over 100,000 companies through channel partnerships.

‍

Notable Investments

SemperVirens has invested in several companies aiming to transform the world of work, health, and financial wellness. While specific names are not provided, their portfolio spans health tech, fintech, and workforce tech sectors, focusing on early-stage companies addressing employer needs.

Website

LinkedIn